Showing results (331-340 of 556) with videos related to
Sort By:
Pageof 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysisElena B Elkin, Milton C Weinstein, Eric P Winer, et al.Journal of the National Cancer Institute|April 22, 2004
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccineSue J Goldie, Michele Kohli, Daniel Grima, et al.BMC Infectious Diseases|May 22, 2013
Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United StatesLisa J McGarry, Kristen E Gilmore, Jaime L Rubin, et al.Substance Use & Misuse|March 29, 2023
A Qualitative Analysis of Hospitalist Perceptions of Self-Directed Discharge Among Inpatients with Opioid Use DisorderMegan K Reed, Nazanin Sarpoulaki, Vignesh Murali, et al.Health Affairs (Project Hope)|July 3, 2015
Despite High Cost, Improved Pneumococcal Vaccine Expected To Return 10-Year Net Savings Of $12 BillionMichele A Kohli, Raymond A Farkouh, Michael J Maschio, et al.La Revue De Medecine Interne|May 1, 1994
[Contribution of morphological imaging in the diagnosis of dementia. I--Alzheimer disease]P Scheltens, D Leys, F Barkhof, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Cost-effectiveness of switching to exemestane after 2 to 3 years of therapy with tamoxifen in postmenopausal women with early-stage breast cancerDavid Thompson, Douglas C A Taylor, Eduardo L Montoya, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 5, 2012
Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host diseaseAmy K O'Sullivan, Milton C Weinstein, Ankur Pandya, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6Andrew H Briggs, Milton C Weinstein, Elisabeth A L Fenwick, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6Andrew H Briggs, Milton C Weinstein, Elisabeth A L Fenwick, et al.Pageof 56